Davis M - Search Results

1

The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in Massachusetts.

Davis M, Strickland K, Easter SR, Worley M Jr, Feltmate C, Muto M, Horowitz N, Berkowitz R, Feldman S. Davis M, et al. Gynecol Oncol. 2018 Jul;150(1):67-72. doi: 10.1016/j.ygyno.2018.05.002. Epub 2018 May 9. Gynecol Oncol. 2018. PMID: 29751992

2

Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: a SEER analysis.

Rauh-Hain JA, Davis M, Clemmer J, Clark RM, Growdon WB, Goodman AK, Boruta DM 2nd, Schorge JO, del Carmen MG. Rauh-Hain JA, et al. Among authors: davis m. Gynecol Oncol. 2013 Nov;131(2):404-9. doi: 10.1016/j.ygyno.2013.08.029. Epub 2013 Sep 1. Gynecol Oncol. 2013. PMID: 24004647

3

Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary.

Davis M, Rauh-Hain JA, Andrade C, Boruta DM 2nd, Schorge JO, Horowitz NS, May T, del Carmen MG. Davis M, et al. Gynecol Oncol. 2014 Mar;132(3):760-6. doi: 10.1016/j.ygyno.2014.01.012. Epub 2014 Jan 16. Gynecol Oncol. 2014. PMID: 24440832 Review.

4

Transitional cell carcinoma of the ovary: a case-control study.

Guseh SH, Rauh-Hain JA, Tambouret RH, Davis M, Clark RM, Boruta DM, Goodman A, Growdon WB, Schorge JO, del Carmen MG. Guseh SH, et al. Among authors: davis m. Gynecol Oncol. 2014 Mar;132(3):649-53. doi: 10.1016/j.ygyno.2014.01.020. Epub 2014 Jan 21. Gynecol Oncol. 2014. PMID: 24462804

5

Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinoma.

Worley MJ Jr, Davis M, Berhie SH, Muto MG, Feltmate CM, Berkowitz RS, Horowitz NS, Campos SM. Worley MJ Jr, et al. Among authors: davis m. Gynecol Oncol. 2014 Oct;135(1):54-7. doi: 10.1016/j.ygyno.2014.07.098. Epub 2014 Aug 1. Gynecol Oncol. 2014. PMID: 25088333

6

Epithelioid trophoblastic tumor: A single institution case series at the New England Trophoblastic Disease Center.

Davis MR, Howitt BE, Quade BJ, Crum CP, Horowitz NS, Goldstein DP, Berkowitz RS. Davis MR, et al. Gynecol Oncol. 2015 Jun;137(3):456-61. doi: 10.1016/j.ygyno.2015.03.006. Epub 2015 Mar 12. Gynecol Oncol. 2015. PMID: 25773203

7

Making Sense of Cervical Cancer Screening Guidelines and Recommendations.

Davis M, Feldman S. Davis M, et al. Curr Treat Options Oncol. 2015 Dec;16(12):55. doi: 10.1007/s11864-015-0373-1. Curr Treat Options Oncol. 2015. PMID: 26467929

8

Investigating the Impact of Body Mass Index on Intraperitoneal Chemotherapy Outcomes in Ovarian and Fallopian Tube Cancer.

Davis M, Aviki E, Rauh-Hain JA, Worley M Jr, Berkowitz R, Schorge J, Muto M, Clark Sisodia R, Horowitz N, Del Carmen M. Davis M, et al. Int J Gynecol Cancer. 2016 Jul;26(6):1033-40. doi: 10.1097/IGC.0000000000000729. Int J Gynecol Cancer. 2016. PMID: 27206282

9

Endosalpingiosis: More than just an incidental finding at the time of gynecologic surgery?

Esselen KM, Terry KL, Samuel A, Elias KM, Davis M, Welch WR, Muto MG, Ng SW, Berkowitz RS. Esselen KM, et al. Among authors: davis m. Gynecol Oncol. 2016 Aug;142(2):255-60. doi: 10.1016/j.ygyno.2016.05.036. Epub 2016 Jun 3. Gynecol Oncol. 2016. PMID: 27261327

10

Human Papillomavirus and Its Testing Assays, Cervical Cancer Screening, and Vaccination.

Zhu Y, Wang Y, Hirschhorn J, Welsh KJ, Zhao Z, Davis MR, Feldman S. Zhu Y, et al. Adv Clin Chem. 2017;81:135-192. doi: 10.1016/bs.acc.2017.01.004. Epub 2017 Mar 18. Adv Clin Chem. 2017. PMID: 28629588 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,878 results

Search Page

Filters